Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
ms decrease » _ decrease (Expand Search), use decreased (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 781 - 800 results of 43,776 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 50 ((ms decrease) OR (a decrease)) ))', query time: 0.79s Refine Results
  1. 781
    Susceptibility of half knockout strains to CYP51 inhibitors (EC50, μM): compounds with decreased activity on HKO + CYP strains.

    Susceptibility of half knockout strains to CYP51 inhibitors (EC50, μM): compounds with decreased activity on HKO + CYP strains. by Laura-Isobel McCall (222498)

    Published 2015
    Save to List
    Saved in:
  2. 782
    Decreased peritumoral myofibroblasts in the MC38 S.C. tumors of <i>S100a4-Cre; Ext1</i><sup><i>f/f</i></sup> mice.

    Decreased peritumoral myofibroblasts in the MC38 S.C. tumors of <i>S100a4-Cre; Ext1</i><sup><i>f/f</i></sup> mice. by Ayumi Niwa (6256790)

    Published 2023
    Save to List
    Saved in:
  3. 783
    KDM6A mRNA expression is decreased in PTFE mice.

    KDM6A mRNA expression is decreased in PTFE mice. by Simon Lebek (9756148)

    Published 2020
    Save to List
    Saved in:
  4. 784
    Body weight, femoral length and <i>Notch3</i> transcripts of 8.5–9 week old male <i>Notch3</i><sup><i>em1Ecan</i></sup> mutant mice (gray bars) and littermate controls (white bars) treated with Notch3 ASO (closed circles) or control ASO (open circles) at 50 mg/kg subcutaneously, once a week for 4 weeks.

    Body weight, femoral length and <i>Notch3</i> transcripts of 8.5–9 week old male <i>Notch3</i><sup><i>em1Ecan</i></sup> mutant mice (gray bars) and littermate controls (white bars)... by Ernesto Canalis (516050)

    Published 2022
    Save to List
    Saved in:
  5. 785
    Acute exercise decreased plasma insulin and glucose.

    Acute exercise decreased plasma insulin and glucose. by Mirian A. Kurauti (3146271)

    Published 2016
    Save to List
    Saved in:
  6. 786
    Signal random fluctuations.

    Signal random fluctuations. by Olga N. Milekhina (812701)

    Published 2017
    Save to List
    Saved in:
  7. 787
    Density plots of normalised consumer final power (PC) for the six example networks, shown over decreasing ratios of mean consumer to mean resource potential, .

    Density plots of normalised consumer final power (PC) for the six example networks, shown over decreasing ratios of mean consumer to mean resource potential, . by Natalie Davis (8556036)

    Published 2020
    “…<p>Each plot shows the density for the normalised consumer final power at = 0.75, 0.5, and 0.25, from left to right, as the ratio decreases due to increased resource flow during the simulation. …”
    Save to List
    Saved in:
  8. 788
    Relative decreases in VP mean weights using VIN against TP controls in eight laboratories (Lab)

    Relative decreases in VP mean weights using VIN against TP controls in eight laboratories (Lab) by William Owens (20777)

    Published 2011
    Save to List
    Saved in:
  9. 789
    LY5 does not inhibit growth of <i>ex vivo</i> pulmonary metastasis.

    LY5 does not inhibit growth of <i>ex vivo</i> pulmonary metastasis. by Peter Y. Yu (4281448)

    Published 2017
    Save to List
    Saved in:
  10. 790
    Five compounds significantly decrease MAPK1 phosphorylation in K562 cells.

    Five compounds significantly decrease MAPK1 phosphorylation in K562 cells. by Pamela Y. Ting (713174)

    Published 2015
    Save to List
    Saved in:
  11. 791
    Effect of specific inhibitors on CYP-mediated CK (50 μM) metabolism in HLMs.

    Effect of specific inhibitors on CYP-mediated CK (50 μM) metabolism in HLMs. by Jian Xiao (253329)

    Published 2016
    Save to List
    Saved in:
  12. 792
    Molecular mass of peak samples of HWHF by LC-MS analysis.

    Molecular mass of peak samples of HWHF by LC-MS analysis. by Prawej Ansari (12191266)

    Published 2022
    Save to List
    Saved in:
  13. 793
    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session.

    Mean ± SD values of unipedal stance parameters evaluated at the different time points of the postural training session. by Cristina Dolciotti (16317330)

    Published 2025
    Save to List
    Saved in:
  14. 794
    Mean pain interference overtime (baseline to 12 weeks).

    Mean pain interference overtime (baseline to 12 weeks). by Judith I. Tsui (5983160)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 795
    Mean pain severity overtime (baseline to 12 weeks).

    Mean pain severity overtime (baseline to 12 weeks). by Judith I. Tsui (5983160)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 796
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 797
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 798
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 799
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 800
    Long-term anti-nucleocapsid response by baseline patient characteristics.

    Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: